A drug profile or pharmacological review entry for retatrutide—covering its mechanism as a triple agonist of GLP-1R, GIPR, and GCGR, its pharmacokinetic properties, clinical trial efficacy data (phase 2 showing ~24% body weight loss), safety profile, and development status. Serves as a concise reference entry for the compound in a pharmacological database or review series.
Ramsbacher, Nathan